3da23e7c A3be 46cb B403 Da4fb78019db 00
Pregabalin Capsule
Product Images NDC 68788-7523
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 68788-7523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
The text shows a graph with the percentage of patients improved in relation to the dosage of Pregabalin, a medication commonly used to treat pain and seizures. The graph demonstrates that patients using higher dosage (450mg) experience a higher rate of improvement in pain compared to those using a lower dosage (300mg) or placebo. The X-axis shows the range of percentage improvement in pain from baseline, while the Y-axis indicates the percentage of patients improved.*
Figure 10 (Pregabalin Fig09)
The text seems to be a chart displaying the estimated percentage of subjects without LTR (which is not mentioned in the given text) over a period of 120 days, with two different treatments: Progabain and Placebo. The estimated percentages range from 0% to 100%, with increments of 10%. The numbers at the bottom indicate the number of days in the treatment.*
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
Percent of subjects improved is being presented in the given text. However, it does not provide any further information or context to understand the scope, purpose or relevance of this information.*
Cockcroft And Gault Equation (Pregabalin Formula)
This appears to be a medical formula for calculating CLCT (creatinine clearance using the Cockcroft-Gault formula) in adult patients. The formula involves subtracting the patient's age (in years) from 140, multiplying the result by their weight in kilograms, and then multiplying that value by 0.85 if the patient is female. The final step is to multiply 72 by the patient's serum creatinine level in milligrams per deciliter (mg/dL).*
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
